Clinical trial success for Cystic Fibrosis gene therapy: built on animal research

This morning the Cystic Fibrosis Gene Therapy Consortium (GTC) announced the results of clinical trial in 140 patients with cystic fibrosis, which demonstrate the potential for gene therapy to slow – and potentially halt - the decline of lung function in people with the disorder. It is a success that is built on 25 years … Continue reading Clinical trial success for Cystic Fibrosis gene therapy: built on animal research

Setting the record straight: Environmental enrichment in animal research.

One of the most important goals of Speaking of Research is to counter the misinformation and mistaken beliefs about animal research that are so prevalent in society, even among those who ought to know better, and a recent series of articles in Ampersand -  the blog of the organization PRIM&R (Public Responsibility in Medicine & … Continue reading Setting the record straight: Environmental enrichment in animal research.

Pro-Test Deutschland: Standing up for science in Germany!

Today we welcome the launch a brand new science advocacy organization, and a new member of the Speaking of Research Family, Pro-Test Deutschland! Pro-Test Deutschland is a grassroots science organization founded by 18 young scientists and supporters of medical progress in the German university town of Tübingen. The need for such a grassroots campaign in … Continue reading Pro-Test Deutschland: Standing up for science in Germany!

European Commission rejects Stop Vivisection Initiative

Today the European Commission rejected the Stop Vivisection Initiative that sought to repeal European Directive 2010/63/EU on the protection of animals used for scientific purposes and ban animal research in the EU. Today, there are effective treatments for many infectious diseases, some forms of cancer, and several chronic diseases such as diabetes. These advancements would … Continue reading European Commission rejects Stop Vivisection Initiative

Lung cancer immunotherapy, from PD-1 knockout mice to clinical trials

This morning many news outlets, including the BBC, covered a very promising development in lung cancer therapy; the successful clinical trial of the cancer immunotherapy Nivolumab in 582 patients with advanced lung cancer. While the extension of survival was modest in most patients, it is to be remembered that these were patients with advanced lung … Continue reading Lung cancer immunotherapy, from PD-1 knockout mice to clinical trials

Stop vivisection Initiative fails to impress at EU hearing

In March we discussed a new attempt by animal rights supporters to ban animal research in Europe, The Stop Vivisection European Citizens’ Initiative, which was signed by  1.2 million people (half of them in Italy). The initiative calls for “the European Commission to abrogate directive 2010/63/EU on the protection of animals used for scientific purposes … Continue reading Stop vivisection Initiative fails to impress at EU hearing

Zebrafish: the rising star of animal models

Today we have a guest article by Jan Botthof, a PhD Student at the Cambridge University Department of Haematology and the world renowned Wellcome Trust Sanger Institute. Together with the EMBL-European Bioinformatics Institute - with which it shares the Genome Campus a few miles south of Cambridge - the Sanger Institutes is one of the … Continue reading Zebrafish: the rising star of animal models

Animal research openness in action – from Cambridge to Florida

Last week we published an article calling on all involved in animal research to speak up for science as animal rights activists held their annual World Week for Animals in Laboratories (WWAIL), writing: This year, if your university or facility is among those that attract attention during WWAIL, we ask that you join in the conversation … Continue reading Animal research openness in action – from Cambridge to Florida